New experimental vaccine for Lou Gehrig's disease gets EU funding

4.7 (702) ·

$ 8.00 ·

In stock

Description

Every month counts: European ALS patients want new drugs

American ALS patients contend with US$158K price tag on new drug

NMR Relaxation Experiments Probe Monomer–Fibril Interaction and

Stem Cells: ALS Treatment Breakthrough (2023)

Gene therapy for ALS: A review: Molecular Therapy

A brief history of ALS awareness and its sparse treatments

The Dish's Weekly News Wrap Up - March 22, 2013

A brief history of ALS awareness and its sparse treatments

New experimental vaccine for Lou Gehrig's disease gets EU funding

Is Covid Getting Less Deadly? - Bloomberg

Frontiers Application of cell-derived exosomes in the

Dying Patients Wait in Vain After Trump-Era Easing of Drug Law

Neurodegenerative Diseases and Treatment